The abstract is read at the publisher; the summary is JClub's.
In 38 clinical Pseudomonas aeruginosa samples, carbapenem/monobactam heteroresistance is prevalent yet hard to detect by VITEK 2, driven by transcriptional differences rather than genetic changes.
- Why it matters: Heteroresistance can hide resistant subpopulations inside susceptible colonies, undermining routine antimicrobial susceptibility testing and leaving mechanisms in Pseudomonas aeruginosa insufficiently defined.
- What they did: The study combined phenotypic screening, whole-genome sequencing with core genome MLST, and quantitative transcriptomics, then tested function using efflux pump and AmpC inhibitors; mexA, ampC, and oprD expression differed, with ParS/ParR linked to oprD (r = -0.797, P < 0.05).
- The result: Resistant and non-resistant subpopulations shared resistance gene repertoires and showed no detectable mutations, amplification, or plasmid acquisition, implying dynamic transcriptional regulation enables survival and suggests gene-targeted diagnostics may miss HR.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.